刺信号通路与乳腺癌中复杂的瘤微环境之间的相互作用:当前知识和治疗前景
Ruijuan Liu1,2, Yang Yu3, Qingyang Wang1
1College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250014, China.
Cell communication and signaling : CCS
|September 9, 2024
概括
乳腺癌的进展是由与瘤微环境 (TME) 相互作用的刺 (Hh) 信号通路驱动的. 了解这些相互作用是开发向乳腺癌治疗的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 乳腺癌的预后和治疗受到瘤微环境 (TME) 的显著影响.
- 刺 (Hh) 信号通路在人类发育和疾病中起着关键作用,其失调与乳腺癌发病,进展和转移有关.
研究的目的:
- 审查Hh通路干扰对乳腺癌TME的影响.
- 探索针对TME进行乳腺癌治疗的Hh通路抑制剂的治疗潜力和挑战.
主要方法:
- 关于乳腺癌TME中Hh通路相互作用的当前理解的文献综述.
- 信号级联的分析及其在乳腺癌发展中的作用.
- 评估涉及Hh通路抑制剂的治疗策略.
主要成果:
- Hh通路的失调是乳腺癌的主要驱动因素.
- Hh通路和TME组件之间的复杂信号相互作用影响癌症生长和转移.
- 路抑制剂显示出治疗前景,但面临临临床挑战.
结论:
- 阐明Hh通路与乳腺癌TME相互作用对于了解乳腺癌风险至关重要.
- 针对性治疗侧重于Hh途径和TME对于新型治疗策略至关重要.
- 克服临床挑战是必要的,以充分利用Hh通路抑制剂的治疗潜力.
更多相关视频
07:03Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
4.5K
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
8.4K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
